Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

 Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

Shots:

  • TScan signs exclusive research and option to license agreement with Qiagen to develop T cell-based laboratory tests for detecting prior exposure to the SARS-CoV-2
  • Qiagen gets an option to license the rights and IP for several of TScan discovered immunodominant T cell targets, associated sequences and relevant data for the development and commercialization of IVD tests. In advance of exercising its option, Qiagen has the right to evaluate TScan’s discoveries
  • The targeted immunodominant were identified through the T-Scan TCR/Target discovery platform enabling the mapping of the specific epitopes in SARS-CoV-2

Click here­ to­ read full press release/ article | Ref: Businesswire | Image: TrialSite News

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post